According to Glenmark Pharmaceuticals 's latest financial reports the company's current earnings are S$1.42 Billion. In 2023 the company made an earning of -S$82.42 Million a decrease over its 2022 earnings that were of S$0.28 Billion. The earnings displayed on this page is the company's Pretax Income.